Cadrenal Therapeutics, Inc. Common Stock (CVKD) Live Share Price, Invest From India

Cadrenal Therapeutics, Inc. Common Stock Stock Performance

as on April 25, 2026 at 2:09 am IST

Day's Low
Day's High
$5.40
Day's Price Range
$5.73
$5.49
1.64%
Downside
4.37%
Upside
52 Week's Low
52 Week's High
$4.21
52-Week Price Range
$17.50
$5.49
23.32%
Downside
218.76%
Upside

Cadrenal Therapeutics, Inc. Common Stock share price movements today

Previous Close: $5.53
Open: $5.50
Volume: 82.2K
Day's Low - High: $5.40 - $5.73
52 Week Low - High: $4.21 - $17.50

Cadrenal Therapeutics, Inc. Common Stock Historical Returns

1 Month Return: -3.49 %
3 Month Return: -23.83 %
1 Year Return: -67.47 %
3 Year Return: -74.92 %
5 Year Return: 0 %

Cadrenal Therapeutics, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Cadrenal Therapeutics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.9M

EPS (TTM)

-5.875

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-13.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-260.11%

Cadrenal Therapeutics, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cadrenal Therapeutics, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cadrenal Therapeutics, Inc. Common Stock	BUY	$13.9M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.4B	129.51%	133.3	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.3B	99.68%	28.57	32.94%
BeiGene, Ltd.	NA	$33.3B	NA	121.87	5.37%
Regeneron Pharmaceuticals Inc	BUY	$78.9B	56.77%	17.99	31.41%

Stock Returns calculator for Cadrenal Therapeutics, Inc. Common Stock Stock including INR - Dollar returns

The Cadrenal Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cadrenal Therapeutics, Inc. Common Stock investment value today

Current value as on today

₹35,664

Returns

-₹64,336

(-64.34%)

Returns from Cadrenal Therapeutics, Inc. Common Stock Stock

-₹67,706 (-67.71%)

Dollar Impact

₹3,369 (+3.37%)

Analyst Recommendation on Cadrenal Therapeutics, Inc. Common Stock Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Cadrenal Therapeutics, Inc. Common Stock. Average target price of $27.67

Cadrenal Therapeutics, Inc. Common Stock Share Price Target

Get share price movements and forecasts by analysts on Cadrenal Therapeutics, Inc. Common Stock.

What analysts predicted

80.16%UPSIDE

Target Price

$27.67

Current Price

$5.49

Analyzed by

8 Analysts

Target

$27.67

Cadrenal Therapeutics, Inc. Common Stock target price $27.67, a slight upside of 80.16% compared to current price of $5.49. According to 8 analysts rating.

Cadrenal Therapeutics, Inc. Common Stock Stock’s Investor Sentiment and Interest

Search interest for Cadrenal Therapeutics, Inc. Common Stock Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 25, 2026 to April 24, 2026

Change:43% versus previous 30 day period

Cadrenal Therapeutics, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	0	-	-	-	0	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-1	-1	-1	-2	-2	-4	-3	-3	-2	-3
EBITDA	-1	-1	-1	-2	-2	-4	-3	-3	-2	-3
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-1	-1	-2	-2	-4	-3	-3	-2	-3
Income Tax Expense	0	0	0	-	-	-	-	-	-	-
Net Income	-1	-1	-1	-2	-2	-4	-3	-3	-2	-3
Net Profit Margin	0.00%	-41331.65%	0.00%	0.00%	0.00%	-196216.92%	0.00%	0.00%	0.00%	0.00%

Cadrenal Therapeutics, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-
Gross Profit	0	0	-
Operating Income	-7	-10	-13
EBITDA	-8	-10	-13
Interest Expense	0	-	-
Depreciation	0	0	0
Income Before Tax	-8	-10	-13
Income Tax Expense	0	-	-
Net Income	-8	-10	-13
Net Profit Margin	0.00%	0.00%	0.00%

Cadrenal Therapeutics, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-1	-1	-2	-2	-4	-3	-3	-2	-3
Operating Cash Flow	0	-1	-1	-2	-1	-4	-3	-2	-2
Investing Cash Flow	-	-	-	-	0	0	0	0	0
Financing Cash Flow	0	0	-	1	7	1	1	0	2
Change in Cash	0	-1	-1	0	5	-2	-1	-1	0

Cadrenal Therapeutics, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Net Income	-8	-10	-13
Operating Cash Flow	-3	-7	-12
Investing Cash Flow	0	0	0
Financing Cash Flow	11	8	6
Change in Cash	8	1	-6

Insights on Cadrenal Therapeutics, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, CVKD stock has moved up by 5.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 53.2% return, outperforming this stock by 128.1%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.3% return, outperforming this stock by 96.8%

About Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

Organisation	Cadrenal Therapeutics, Inc. Common Stock
Headquarters	822 A1A North, Ponte Vedra, FL, United States, 32082
Industry	Biotechnology
CEO	Mr. Quang X. Pham
E-voting on shares	Click here to vote

Key Management of Cadrenal Therapeutics, Inc. Common Stock

Name	Title
Mr. Quang X. Pham	Chairman & CEO
Mr. Matthew K. Szot CPA	Co-Founder & CFO
Dr. James J. Ferguson FACC, M.D.	Chief Medical Officer
Mr. Jeffrey Cole	Chief Operating Officer
Dr. Matthew Boxer M.B.A., Ph.D.	Executive Vice President of Corporate Development

FAQs

What is Cadrenal Therapeutics, Inc. Common Stock share price today?

Cadrenal Therapeutics, Inc. Common Stock share price today is $5.49 as on April 24, 2026 at 8:39 pm IST. Cadrenal Therapeutics, Inc. Common Stock share today touched a day high of $5.73 and a low of $5.4.

What is the 52 week high and 52 week low for Cadrenal Therapeutics, Inc. Common Stock share?

Cadrenal Therapeutics, Inc. Common Stock share touched a 52 week high of $17.5 on April 28, 2025 and a 52 week low of $4.21 on March 30, 2026. Cadrenal Therapeutics, Inc. Common Stock stock price today i.e. April 24, 2026 at 8:39 pm IST is trending at $5.49,which is 68.63% down from its 52 week high and 30.40% up from its 52 week low.

What is Cadrenal Therapeutics, Inc. Common Stock's market capitalisation today?

Cadrenal Therapeutics, Inc. Common Stock market capitalisation is $0.00T as on April 24, 2026 at 8:39 pm IST.

How to invest in Cadrenal Therapeutics, Inc. Common Stock Stock (CVKD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cadrenal Therapeutics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cadrenal Therapeutics, Inc. Common Stock Shares that will get you 0.2732 shares as per Cadrenal Therapeutics, Inc. Common Stock share price of $5.49 per share as on April 24, 2026 at 8:39 pm IST.

What is the minimum amount required to buy Cadrenal Therapeutics, Inc. Common Stock Stock (CVKD) from India?

Indian investors can start investing in Cadrenal Therapeutics, Inc. Common Stock (CVKD) shares with as little as ₹94.228 or $1 (as of April 24, 2026 at 8:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in Cadrenal Therapeutics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on April 24, 2026 at 8:42 pm IST). Based on Cadrenal Therapeutics, Inc. Common Stock share’s latest price of $5.49 as on April 24, 2026 at 8:39 pm IST, you will get 1.8215 shares of Cadrenal Therapeutics, Inc. Common Stock. Learn more about fractional shares .